Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity-Reference-Cited by-同舟云学术

Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity

Published:2020-08-17 Issue:9 Volume:11 Page:1667-1670
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Fernández Ariel¹²³^ORCID

Affiliation:

1. CONICET, National Research Council, Avenida Rivadavia 1917, Buenos Aires 1033, Argentina

2. INQUISUR/UNS/CONICET, Avenida Alem 1253, Bahı́a Blanca 8000, Argentina

3. Daruma Institute for AI in Pharmaceutical Research, AF Innovation Pharma Consultancy GmbH, 4000 Pemberton Court, Winston-Salem, North Carolina 27106, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00410

Reference8 articles.

1. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

2. D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

3. Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry

4. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

5. Physics at the Biomolecular Interface

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological storm and multiple organ damage by COVID-19;Medicine in Omics;2024-08

2. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages;mBio;2023-06-29

3. Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions;Journal of Virology;2023-03-30

4. Use of the D614G Mutation of the SARS-CoV-2 Spike Protein as a Biophysical Model to Explain Coulomb’s Law Function;Creative Education;2023

5. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses;Biomedical Engineering Advances;2022-12